Profile | GDS4284 / 221764_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 8714.67 | 97 |
GSM687648 | Patient 402 control | 18363.7 | 99 |
GSM687653 | Patient 403 control | 6659.63 | 95 |
GSM687658 | Patient 404 control | 12568.3 | 98 |
GSM687663 | Patient 411 control | 16217.8 | 98 |
GSM687668 | Patient 422 control | 11129.2 | 97 |
GSM687673 | Patient 424 control | 14818.6 | 98 |
GSM687678 | Patient 425 control | 15046.3 | 98 |
GSM687683 | Patient 427 control | 14845.3 | 98 |
GSM687688 | Patient 428 control | 11877.7 | 98 |
GSM687695 | Patient 441 control | 74379.1 | 99 |
GSM687699 | Patient 443 control | 15359.1 | 98 |
GSM687704 | Patient 444 control | 12747.5 | 98 |
GSM687707 | Patient 448 control | 7380.55 | 96 |
GSM687712 | Patient 449 control | 10512.8 | 97 |
GSM687719 | Patient 450 control | 24246.4 | 99 |
GSM687724 | Patient 451 control | 14782.3 | 98 |
GSM687728 | Patient 452 control | 15589.6 | 98 |
GSM687646 | Patient 401 treated 24h | 5324.85 | 94 |
GSM687649 | Patient 402 treated 24h | 15830.5 | 98 |
GSM687665 | Patient 411 treated 24h | 14430.3 | 98 |
GSM687651 | Patient 402 treated 4 weeks | 22792.9 | 99 |
GSM687667 | Patient 411 treated 4 weeks | 8923 | 97 |
GSM687670 | Patient 422 treated 24h | 8722.14 | 97 |
GSM687671 | Patient 422 treated 4 weeks | 10782.9 | 97 |
GSM687654 | Patient 403 treated 24h | 8122.15 | 96 |
GSM687675 | Patient 424 treated 24h | 18435 | 99 |
GSM687685 | Patient 427 treated 24h | 21639.1 | 99 |
GSM687656 | Patient 403 treated 4 weeks | 10613.6 | 97 |
GSM687677 | Patient 424 treated 4 weeks | 14558.3 | 98 |
GSM687687 | Patient 427 treated 4 weeks | 8354.07 | 96 |
GSM687692 | Patient 428 treated 4h | 7896.26 | 96 |
GSM687716 | Patient 449 treated 4h | 8463.76 | 96 |
GSM687722 | Patient 450 treated 4h | 21334.8 | 99 |
GSM687680 | Patient 425 treated 24h | 14264.7 | 98 |
GSM687690 | Patient 428 treated 24h | 11052.7 | 97 |
GSM687700 | Patient 443 treated 24h | 39269.2 | 99 |
GSM687705 | Patient 444 treated 24h | 11043.1 | 97 |
GSM687714 | Patient 449 treated 24h | 9443.79 | 97 |
GSM687721 | Patient 450 treated 24h | 45467.6 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 12419.8 | 98 |
GSM687694 | Patient 428 treated 4 weeks | 12817.6 | 98 |
GSM687702 | Patient 443 treated 4 weeks | 17622.5 | 99 |
GSM687718 | Patient 449 treated 4 weeks | 10642.1 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 13989.9 | 98 |
GSM687661 | Patient 404 treated 4h | 9629.21 | 97 |
GSM687710 | Patient 448 treated 4h | 10105.1 | 97 |
GSM687726 | Patient 451 treated 4h | 15728.9 | 98 |
GSM687730 | Patient 452 treated 4h | 4820.39 | 94 |
GSM687660 | Patient 404 treated 24h | 29938.9 | 99 |
GSM687697 | Patient 441 treated 24h | 39441 | 99 |
GSM687709 | Patient 448 treated 24h | 8127.95 | 96 |
GSM687725 | Patient 451 treated 24h | 15039 | 98 |
GSM687729 | Patient 452 treated 24h | 36204.5 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 15464.7 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 13594.9 | 98 |